Arcus Biosciences
arcusbio.com
Actively hiring
Oncology Therapeutics
Prescription Drugs
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
Overview
Arcus Biosciences is a rapidly growing, clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines that may have the potential to help people with cancer live longer. Located in the San Francisco bay area, Arcus Biosciences offers a competitive compensation and benefits package, including aggressive participation in the growth of the company in the form of stock option grants. Arcus has an ambitious undertaking and expects to become a force in the discovery, development and commercialization of novel combination therapies to treat cancer in areas of high unmet need.
News
From Target to Translation: Revealing the Mechanism Behind HIF-2α Inhibition in Kidney Cancer
A look at how ARC-20 connected tumor biology, blood-based biomarkers and clinical outcomes for casdatifan in kidney cancer.
Read more
Report
Arcus Outlines 2026 Plans for Casdatifan, its Potential Best-in-Class HIF-2a Inhibitor, and its Inflammation Programs
Read more
Report
Combining for Change in Kidney Cancer
While there has been substantial progress in treatment in recent years, even more innovative approaches are needed to improve survival, especially when the cancer is metastatic, meaning it has spread to other parts of the body.
Read more
Report
From Paper to Pill
There is opportunity to develop new and potentially improved molecules that block HIF-2α to further improve outcomes.
Read more
Report
Addressing Adenosine: Immunotherapy in the Tumor Microenvironment
Targeting the adenosine axis - components that contribute to the production of adenosine and its subsequent impact - is a promising option.
Read more
Report
The Fc-silent Treatment: Pursuing a Known Target in a New Way
Arcus was among the first to take a different approach and pursue an Fc-silent anti-TIGIT antibody based on our own scientific understanding of how this biological pathway works.
Read more
Report
"Cricket is Life in a Nutshell": Arcus Executive Arun Tholudur Talks Longtime Passion for Cricket, How it Intersects with Drug Development
Arun Tholudur is SVP, Pharmaceutical Development & Manufacturing at Arcus. We sat down with him to discuss his love for playing cricket, his experience playing on the Masters Cricket USA National Cricket Team, and how lessons he's learned from the sport a
Read more
Report
Investigating Combination Therapies to Treat Cancer
Learn how cancer biology is guiding the study of potential, new combination medicines to treat specific types of cancer.
Read more
Report
A Peek Into the Platform: How an Innovative Trial Design Can Accelerate Drug Development
To evaluate the growing number of treatment options for cancer efficiently and rigorously, we need to rethink the way we approach early clinical trials.
Read more
Report
What Biotech Companies Can Learn from Consumer Tech Outliers
Patients are waiting, so life sciences companies must embrace change and evolve their thinking.
Read more
Report
Show more news
Tech stack
Technologies named in job postings at Arcus Biosciences over the last 12 months, by layer, with the share of postings for each.
Technologies in use
5
Postings analysed
1
Stack modernity
64/100
Languages
SAS
Cloud & platforms
AWS
Active Directory
Okta
Developer tools
CAPA
Sign in to see how your skills match this stack
Sign In
Salary insights
Compensation ranges based on this company's open jobs
Median
$185k
Typical range
$185k
Open positions
1
1
Jobs
Senior
100%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Senior | 1 | $185k | $185k |
Highest paying role
Senior Manager, IT Qualification & Validation
$185k
Normalized to USD per year
Growth
Hiring Momentum
28/100
Slowing
Open positions
1
0 opened / 0 closed in 30 days
ATS activity
Every ~4 hours
10/16/2026
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Management
100% ▲